EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Chemokine Receptor-5 Δ 32 Mutation is No Risk Factor for Ischemic-Type Biliary Lesion in Liver Transplantation

Christoph Heidenhain, Gero Puhl, Christian Moench, Anja Lautem, Peter Neuhaus

Journal of Transplantation · 2009

DOI: 10.1155/2009/436515 ↗
AbstractBibliografische Angaben

Abstract

It has been shown that certain chemokine receptor polymorphisms may correspond to certain complications after organ transplantation. Ischemic-type biliary lesion (ITBL) encounters for major morbidity and mortality in liver transplant recipients. So far, the exact cause for ITBL remains unclear. Certain risk factors for the development of ITBL like donor age and cold ischemic time are well described. In a previous study, a 32-nucleotide deletion of the chemokine receptor-5 Δ 32 (CCR-5 Δ 32) was strongly associated with the incidence of ITBL in adult liver transplantation. This study re-evaluates the association of CCR-5 Δ 32 gene polymorphism and the incidence of ITBL. 169 patients were included into this retrospective analysis. 134 patients were homozygous for wild-type CCR-5, 33 patients heterozygous, and 2 patients were homozygous for CCR-5 Δ 32 mutation. There were no major differences in donor or recipients demographics. No association was found between CCR-5 Δ 32 mutation and the development of ITBL. We conclude that CCR-5 Δ 32 is no risk factor for the development of ITBL in our patient cohort.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →